SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-024675
Filing Date
2022-11-14
Accepted
2022-11-14 07:14:50
Documents
15
Period of Report
2022-11-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cogt-20221114.htm   iXBRL 8-K 83803
2 EX-99.1 cogt-ex99_1.htm EX-99.1 178892
3 GRAPHIC img214414700_0.jpg GRAPHIC 78289
  Complete submission text file 0000950170-22-024675.txt   535487

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cogt-20221114.xsd EX-101.SCH 2902
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cogt-20221114_lab.xml EX-101.LAB 16972
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cogt-20221114_def.xml EX-101.DEF 13901
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cogt-20221114_pre.xml EX-101.PRE 13946
9 EXTRACTED XBRL INSTANCE DOCUMENT cogt-20221114_htm.xml XML 6170
Mailing Address 275 WYMAN STREET 3RD FLOOR WALTHAM MA 02451
Business Address 275 WYMAN STREET 3RD FLOOR WALTHAM MA 02451 617-945-5576
Cogent Biosciences, Inc. (Filer) CIK: 0001622229 (see all company filings)

IRS No.: 465308248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38443 | Film No.: 221380160
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences